{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:27:14Z","timestamp":1753892834548,"version":"3.41.2"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Menopause is a significant phase in a woman\u2019s life and is characterized by the cessation of ovarian function and a decline in endogenous ovarian hormone levels. This hormonal transition is often accompanied by debilitating symptoms, such as hot flushes, which can significantly impair quality of life. Hormone replacement therapy (HRT) is commonly used to alleviate these symptoms; however, there are concerns regarding its safety, particularly its impact on psychiatric health, in real-world settings. This study aimed to systemically investigate the psychiatric risks associated with HRT in menopausal women using real-world data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted disproportionality analyses by using data from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) collected from January 1, 2004, to September 30, 2024, to calculate the reporting odds ratio (ROR) for psychiatric adverse events (pAEs) across four FDA-approved HRT categories. Risk factors for pAEs were further explored by multivariate logistic regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 43,340 HRT-related adverse event reports, 2,840 (6.6%) involved pAEs, with a median patient age of 59 years (IQR: 52\u201367). A total of 43 pAEs at the preferred term level were identified associated with HRT. After adjustment for confounders, HRT related pAEs revealed an increased risk in females younger than 40 years old. Furthermore, those taking HRT by systemic route had higher risk of pAEs than local administration. Additionally, for different HRT type, only estrogen alone or estrogen combined progestogen had increased risk for HRT-related pAEs. Specifically, estrogen monotherapy was associated with an increased risk of mood disorder (OR=1.83, 95%CI: 1.42\u20132.37) and sleep disturbances (OR=1.57, 95%CI: 1.26\u20131.98)- related pAEs, while a reduced risk of suicidal and self-injurious behavior (OR=0.33, 95%CI: 0.18\u22120.61)-related pAEs comparing with combination therapy with progestogen. Notably, only combination therapy increased the risk of pAEs related to depressed mood and disturbances.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>It is necessary to conduct personalized risk stratification in HRT management, prioritizing age, administration route, and regimen type. While, further clinical investigations are needed to validate these findings and refine HRT safety strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1614087","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T14:22:00Z","timestamp":1751034120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychiatric safety associated with hormone replacement therapy for menopausal symptoms: a real-world study of the FDA adverse event reporting system"],"prefix":"10.3389","volume":"16","author":[{"given":"Nan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-li","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.08.016","article-title":"Menopause-Biology, consequences, supportive care, and therapeutic options","volume":"186","author":"Davis","year":"2023","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2023.101855","article-title":"Menopause: Physiology, definitions, and symptoms","volume":"38","author":"Gatenby","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bpobgyn.2021.12.001","article-title":"Hormone replacement therapy - Current recommendations","volume":"81","author":"Vigneswaran","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/1745506519864009","article-title":"Hormone therapy for first-line management of menopausal symptoms: Practical recommendations","volume":"15","author":"Palacios","year":"2019","journal-title":"Womens Health (Lond)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.39491","article-title":"Association of hormone therapy with depression during menopause in a cohort of Danish women","volume":"5","author":"Wium-Andersen","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.09.068","article-title":"Suicidal ideation among postmenopausal women on hormone replacement therapy: The Korean National Health and Nutrition Examination Survey (KNHANES V) from 2010 to 2012","volume":"189","author":"Lee","year":"2016","journal-title":"J Affect Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/mlr.0000000000001433","article-title":"Menopausal hormone therapy and suicide in a national sample of midlife and older women veterans","volume":"59","author":"Gibson","year":"2021","journal-title":"Med Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001833","article-title":"Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS-cognitive and affective study","volume":"12","author":"Gleason","year":"2015","journal-title":"PloS Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.3998","article-title":"Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: A randomized clinical trial","volume":"75","author":"Gordon","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.5.591","article-title":"Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen\/Progestin Replacement Study (HERS) trial","volume":"287","author":"Hlatky","year":"2002","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/gme.0b013e31823bcec5","article-title":"Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms","volume":"19","author":"Yalamanchili","year":"2012","journal-title":"Menopause"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1017\/s2045796016001220","article-title":"Hysterectomy and incidence of depressive symptoms in midlife women: the Australian Longitudinal Study on Women\u2019s Health","volume":"27","author":"Wilson","year":"2018","journal-title":"Epidemiol Psychiatr Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0000000000000712","article-title":"Depressive symptoms across the menopause transition: findings from a large population-based cohort study","volume":"23","author":"Hickey","year":"2016","journal-title":"Menopause"},{"key":"B16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s43440-022-00444-2","article-title":"Estrogen fluctuations during the menopausal transition are a risk factor for depressive disorders","volume":"75","author":"Turek","year":"2023","journal-title":"Pharmacol Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s44220-024-00292-4","article-title":"Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause","volume":"2","author":"Shitomi-Jones","year":"2024","journal-title":"Nat Ment Health"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1017\/s0033291714002773","article-title":"Risk factors for major depression during midlife among a community sample of women with and without prior major depression: are they the same or different","volume":"45","author":"Bromberger","year":"2015","journal-title":"Psychol Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11523-021-00865-8","article-title":"Psychiatric adverse reactions to anaplastic lymphoma kinase inhibitors in non-small-cell lung cancer: analysis of spontaneous reports submitted to the FDA adverse event reporting system","volume":"17","author":"Sisi","year":"2022","journal-title":"Target Oncol"},{"key":"B20","unstructured":"FDA adverse event reporting system\n          \n          \n          \n          2018"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)02801-5","article-title":"Promoting good mental health over the menopause transition","volume":"403","author":"Brown","year":"2024","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200326030-00002","article-title":"Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA)","volume":"26","author":"Brown","year":"2003","journal-title":"Drug Saf"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.2653","article-title":"Association of age at menopause and duration of reproductive period with depression after menopause: A systematic review and meta-analysis","volume":"73","author":"Georgakis","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.04.041","article-title":"The risk of depression in the menopausal stages: A systematic review and meta-analysis","volume":"357","author":"Badawy","year":"2024","journal-title":"J Affect Disord"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0000000000001229","article-title":"Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy","volume":"25","author":"Rocca","year":"2018","journal-title":"Menopause"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.26538","article-title":"Previous pregnancies might mitigate cortical brain differences associated with surgical menopause","volume":"45","author":"Fern\u00e1ndez-Pena","year":"2024","journal-title":"Hum Brain Mapp"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.1590","article-title":"Association of salpingectomy with delayed oophorectomy versus salpingo-oophorectomy with quality of life in BRCA1\/2 pathogenic variant carriers: A nonrandomized controlled trial","volume":"7","author":"Steenbeek","year":"2021","journal-title":"JAMA Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.12703\/r\/10-25","article-title":"Modern management of genitourinary syndrome of menopause","volume":"10","author":"Silva","year":"2021","journal-title":"Fac Rev"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40141","article-title":"A review and meta-analysis of the prevalence and health impact of polycystic ovary syndrome among medical and dental students","volume":"15","author":"Coffin","year":"2023","journal-title":"Cureus"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.821908","article-title":"Academic and social impact of menstrual disturbances in female medical students: A systematic review and meta-analysis","volume":"9","author":"Maity","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1017\/s2045796022000439","article-title":"Depressive symptoms and suicidality by menopausal stages among middle-aged Korean women","volume":"31","author":"An","year":"2022","journal-title":"Epidemiol Psychiatr Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40478-024-01733-y","article-title":"Progesterone receptor distribution in the human hypothalamus and its association with suicide","volume":"12","author":"Zhang","year":"2024","journal-title":"Acta Neuropathol Commun"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1614087\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T14:22:01Z","timestamp":1751034121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1614087\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":32,"alternative-id":["10.3389\/fpsyt.2025.1614087"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1614087","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"article-number":"1614087"}}